Correlation Between Gilead Sciences and Imunon
Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and Imunon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and Imunon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gilead Sciences and Imunon Inc, you can compare the effects of market volatilities on Gilead Sciences and Imunon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of Imunon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and Imunon.
Diversification Opportunities for Gilead Sciences and Imunon
-0.77 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Gilead and Imunon is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and Imunon Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Imunon Inc and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with Imunon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Imunon Inc has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and Imunon go up and down completely randomly.
Pair Corralation between Gilead Sciences and Imunon
Given the investment horizon of 90 days Gilead Sciences is expected to generate 0.37 times more return on investment than Imunon. However, Gilead Sciences is 2.68 times less risky than Imunon. It trades about 0.08 of its potential returns per unit of risk. Imunon Inc is currently generating about -0.11 per unit of risk. If you would invest 8,984 in Gilead Sciences on September 3, 2024 and sell it today you would earn a total of 274.00 from holding Gilead Sciences or generate 3.05% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Gilead Sciences vs. Imunon Inc
Performance |
| Timeline |
| Gilead Sciences |
| Imunon Inc |
Gilead Sciences and Imunon Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Gilead Sciences and Imunon
The main advantage of trading using opposite Gilead Sciences and Imunon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, Imunon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Imunon will offset losses from the drop in Imunon's long position.| Gilead Sciences vs. Pfizer Inc | Gilead Sciences vs. Johnson Johnson | Gilead Sciences vs. Highway Holdings Limited | Gilead Sciences vs. QCR Holdings |
| Imunon vs. Exicure | Imunon vs. Cyclacel Pharmaceuticals | Imunon vs. Histogen | Imunon vs. DiaMedica Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |